Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer

Hirofumi Yamamoto; Mitsuyoshi Tei; Mamoru Uemura; Ichiro Takemasa; Yoshio Uemura; Kohei Murata; Mutsumi Fukunaga; Masayuki Ohue; Tadashi Ohnishi; Kimimasa Ikeda; Takeshi Kato; Shu Okamura; Masakazu Ikenaga; Naotsugu Haraguchi; Junichi Nishimura; Tsunekazu Mizushima; Koshi Mimori; Yuichiro Doki; Masaki Mori

doi:10.3892/ijo.2012.1750

Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer

Hirofumi Yamamoto, Mitsuyoshi Tei, Mamoru Uemura, Ichiro Takemasa, Yoshio Uemura, Kohei Murata, Mutsumi Fukunaga, Masayuki Ohue, Tadashi Ohnishi, Kimimasa Ikeda, Takeshi Kato, Shu Okamura, Masakazu Ikenaga, Naotsugu Haraguchi, Junichi Nishimura, Tsunekazu Mizushima, Koshi Mimori, Yuichiro Doki, Masaki Mori

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Abstract

We previously studied hypoxic tumor cells from hepatic metastases of colorectal cancer (CRC) and determined several potential prognostic factors, including expression of ephrin-A1 (EFNA1), which was highly induced by hypoxia. Here, we further evaluated the prognostic impact of EFNA1 expression. Samples from a total of 366 CRC patients from 11 institutes were analyzed by either microarray (n=220) or quantitative reverse-transcriptase polymerase chain reaction (n=146). EFNA1 was an independent prognostic factor for CRC (p<0.05). In vitro assays revealed that loss of EFNA1 following siRNA treatment was associated with reduced proliferative activity and decreased invasion and migration of CRC cell lines. EFNA1 expression is a useful marker for predicting high risk of relapse and cancer-related death in patients who have undergone curative resection for CRC.

Original language	English
Pages (from-to)	549-555
Number of pages	7
Journal	International journal of oncology
Volume	42
Issue number	2
DOIs	https://doi.org/10.3892/ijo.2012.1750
Publication status	Published - Feb 2013

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.3892/ijo.2012.1750

Fingerprint Dive into the research topics of 'Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer'. Together they form a unique fingerprint.

Cite this

Yamamoto, H., Tei, M., Uemura, M., Takemasa, I., Uemura, Y., Murata, K., Fukunaga, M., Ohue, M., Ohnishi, T., Ikeda, K., Kato, T., Okamura, S., Ikenaga, M., Haraguchi, N., Nishimura, J., Mizushima, T., Mimori, K., Doki, Y., & Mori, M. (2013). Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer. International journal of oncology, 42(2), 549-555. https://doi.org/10.3892/ijo.2012.1750

Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer. / Yamamoto, Hirofumi; Tei, Mitsuyoshi; Uemura, Mamoru; Takemasa, Ichiro; Uemura, Yoshio; Murata, Kohei; Fukunaga, Mutsumi; Ohue, Masayuki; Ohnishi, Tadashi; Ikeda, Kimimasa; Kato, Takeshi; Okamura, Shu; Ikenaga, Masakazu; Haraguchi, Naotsugu; Nishimura, Junichi; Mizushima, Tsunekazu; Mimori, Koshi; Doki, Yuichiro; Mori, Masaki.

In: International journal of oncology, Vol. 42, No. 2, 02.2013, p. 549-555.

Research output: Contribution to journal › Article › peer-review

Yamamoto, H, Tei, M, Uemura, M, Takemasa, I, Uemura, Y, Murata, K, Fukunaga, M, Ohue, M, Ohnishi, T, Ikeda, K, Kato, T, Okamura, S, Ikenaga, M, Haraguchi, N, Nishimura, J, Mizushima, T, Mimori, K, Doki, Y & Mori, M 2013, 'Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer', International journal of oncology, vol. 42, no. 2, pp. 549-555. https://doi.org/10.3892/ijo.2012.1750

Yamamoto, Hirofumi ; Tei, Mitsuyoshi ; Uemura, Mamoru ; Takemasa, Ichiro ; Uemura, Yoshio ; Murata, Kohei ; Fukunaga, Mutsumi ; Ohue, Masayuki ; Ohnishi, Tadashi ; Ikeda, Kimimasa ; Kato, Takeshi ; Okamura, Shu ; Ikenaga, Masakazu ; Haraguchi, Naotsugu ; Nishimura, Junichi ; Mizushima, Tsunekazu ; Mimori, Koshi ; Doki, Yuichiro ; Mori, Masaki. / Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer. In: International journal of oncology. 2013 ; Vol. 42, No. 2. pp. 549-555.

@article{372c7f83538c4704a7559aed1436999e,

title = "Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer",

abstract = "We previously studied hypoxic tumor cells from hepatic metastases of colorectal cancer (CRC) and determined several potential prognostic factors, including expression of ephrin-A1 (EFNA1), which was highly induced by hypoxia. Here, we further evaluated the prognostic impact of EFNA1 expression. Samples from a total of 366 CRC patients from 11 institutes were analyzed by either microarray (n=220) or quantitative reverse-transcriptase polymerase chain reaction (n=146). EFNA1 was an independent prognostic factor for CRC (p<0.05). In vitro assays revealed that loss of EFNA1 following siRNA treatment was associated with reduced proliferative activity and decreased invasion and migration of CRC cell lines. EFNA1 expression is a useful marker for predicting high risk of relapse and cancer-related death in patients who have undergone curative resection for CRC.",

author = "Hirofumi Yamamoto and Mitsuyoshi Tei and Mamoru Uemura and Ichiro Takemasa and Yoshio Uemura and Kohei Murata and Mutsumi Fukunaga and Masayuki Ohue and Tadashi Ohnishi and Kimimasa Ikeda and Takeshi Kato and Shu Okamura and Masakazu Ikenaga and Naotsugu Haraguchi and Junichi Nishimura and Tsunekazu Mizushima and Koshi Mimori and Yuichiro Doki and Masaki Mori",

year = "2013",

month = feb,

doi = "10.3892/ijo.2012.1750",

language = "English",

volume = "42",

pages = "549--555",

journal = "International Journal of Oncology",

issn = "1019-6439",

publisher = "Spandidos Publications",

number = "2",

}

TY - JOUR

T1 - Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer

AU - Yamamoto, Hirofumi

AU - Tei, Mitsuyoshi

AU - Uemura, Mamoru

AU - Takemasa, Ichiro

AU - Uemura, Yoshio

AU - Murata, Kohei

AU - Fukunaga, Mutsumi

AU - Ohue, Masayuki

AU - Ohnishi, Tadashi

AU - Ikeda, Kimimasa

AU - Kato, Takeshi

AU - Okamura, Shu

AU - Ikenaga, Masakazu

AU - Haraguchi, Naotsugu

AU - Nishimura, Junichi

AU - Mizushima, Tsunekazu

AU - Mimori, Koshi

AU - Doki, Yuichiro

AU - Mori, Masaki

PY - 2013/2

Y1 - 2013/2

N2 - We previously studied hypoxic tumor cells from hepatic metastases of colorectal cancer (CRC) and determined several potential prognostic factors, including expression of ephrin-A1 (EFNA1), which was highly induced by hypoxia. Here, we further evaluated the prognostic impact of EFNA1 expression. Samples from a total of 366 CRC patients from 11 institutes were analyzed by either microarray (n=220) or quantitative reverse-transcriptase polymerase chain reaction (n=146). EFNA1 was an independent prognostic factor for CRC (p<0.05). In vitro assays revealed that loss of EFNA1 following siRNA treatment was associated with reduced proliferative activity and decreased invasion and migration of CRC cell lines. EFNA1 expression is a useful marker for predicting high risk of relapse and cancer-related death in patients who have undergone curative resection for CRC.

AB - We previously studied hypoxic tumor cells from hepatic metastases of colorectal cancer (CRC) and determined several potential prognostic factors, including expression of ephrin-A1 (EFNA1), which was highly induced by hypoxia. Here, we further evaluated the prognostic impact of EFNA1 expression. Samples from a total of 366 CRC patients from 11 institutes were analyzed by either microarray (n=220) or quantitative reverse-transcriptase polymerase chain reaction (n=146). EFNA1 was an independent prognostic factor for CRC (p<0.05). In vitro assays revealed that loss of EFNA1 following siRNA treatment was associated with reduced proliferative activity and decreased invasion and migration of CRC cell lines. EFNA1 expression is a useful marker for predicting high risk of relapse and cancer-related death in patients who have undergone curative resection for CRC.

UR - http://www.scopus.com/inward/record.url?scp=84873658823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873658823&partnerID=8YFLogxK

U2 - 10.3892/ijo.2012.1750

DO - 10.3892/ijo.2012.1750

M3 - Article

C2 - 23258614

AN - SCOPUS:84873658823

VL - 42

SP - 549

EP - 555

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 2

ER -